← Leaderboards
Xu Feng
University Of Alabama At Birmingham
$5,639,145
Attributed
$5,871,714
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $548K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,871,714 · 5
By mechanism
R01$4,661,856 · 1
R21$1,209,858 · 4
Top collaborators
- Ashish Kumar Pathak2 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- Ping Zhang$3,382,120
- Selvarangan Ponnazhagan$11,274,357
- Jay M McDonald$5,565,578
- Jessica M Grunda$58,442
Others in their field
Top investigators on “Osteoclasts”
- Brendan Hl Lee · Baylor College Of Medicine$18,789,257
- Steven L Teitelbaum · Washington University$16,498,459
- Mone Zaidi · Icahn School Of Medicine At Mount Sinai$16,089,949
- Karl Leonard Insogna · Yale University$15,344,415
- Yi-Ping Li · Tulane University Of Louisiana$14,733,549
- Yongwon Choi · University Of Pennsylvania$14,421,139
Research focus
OsteoclastsMacrophageCytoplasmic TailReceptorSignal PathwayMediatingPathway InteractionsBaseIn VivoIn VitroSignal TransductionPlayTnf Receptor-Associated FactorsProteinsMapk14 GeneMapk8 GeneMemberTumorRecruitment ActivityRheumatoid ArthritisCellsBone DiseasesPostmenopausal OsteoporosisTumor Necrosis Factor Receptor
Grant awards (22)
RANK Signaling Inhibitors for Osteolytic Lesions in Multiple Myeloma$201,609
R21 · FY2025 · CA · contact PI
Development of Targeted Drugs for Osteoporosis$277,279
R21 · FY2020 · AR · contact PI
Discovery of Novel Drug Targets for Breast Cancer$187,979
R21 · FY2019 · CA · contact PI
Development of Targeted Drugs for Osteoporosis$187,859
R21 · FY2019 · AR · contact PI
Discovery of Novel Drug Targets for Breast Cancer$161,494
R21 · FY2018 · CA · contact PI
RANK Signaling in Osteoclast Differentiation and Function$329,625
R01 · FY2016 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$329,625
R01 · FY2015 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$323,033
R01 · FY2014 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$313,144
R01 · FY2013 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$329,625
R01 · FY2012 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$303,662
R01 · FY2010 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$328,543
R01 · FY2009 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$327,119
R01 · FY2008 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$332,385
R01 · FY2007 · AR · contact PI
Cell-Based Assays for Identifying Anti-RANK Signaling Agents$193,638
R21 · FY2007 · NS · contact PI
RANK Signaling in Osteoclast Differentiation and Function$22,005
R01 · FY2007 · AR · contact PI
RANK Signaling in Osteoclast Differentiation and Function$288,090
R01 · FY2006 · AR · contact PI
RANK Signaling in Osteoclast Differentiation &Function$287,000
R01 · FY2005 · AR
RANK Signaling in Osteoclast Differentiation &Function$287,000
R01 · FY2004 · AR
RANK Signaling in Osteoclast Differentiation &Function$287,000
R01 · FY2003 · AR
RANK Signaling in Osteoclast Differentiation &Function$287,000
R01 · FY2002 · AR
RANK Signaling in Osteoclast Differentiation &Function$287,000
R01 · FY2001 · AR